中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2013年
12期
2034-2034,2036
,共2页
乳腺增生%舒乳散%消结汤%临床分析
乳腺增生%舒乳散%消結湯%臨床分析
유선증생%서유산%소결탕%림상분석
Hyperplasia of mammary glands%Shurusan%External%Clinical research
目的:探讨消结汤内服合舒乳散外用治疗乳腺增生病临床分析。方法:100例患者都符合2002年中华中医外科学会乳腺病专业委员会八次会议的乳腺增生的诊断标准,分为两组,治疗组运用消结汤内服合舒乳散外用进行治疗,观察其治疗效果。结果:治疗组50例中,治愈34例,占68%;显效7例,占14%;好转7例,占14%;无效2例,占4%;总有效率为96%。对照组50例中.治愈9例,占18%;显效11例,占22%;好转19例,占38%;无效11例,占22%;总有效率为78%。治疗组总有效率优于对照组,差异有统计学意义(P<0.05)。结论:消结汤内服合舒乳散外用治疗乳腺增生病的临床效果好,值得推广。
目的:探討消結湯內服閤舒乳散外用治療乳腺增生病臨床分析。方法:100例患者都符閤2002年中華中醫外科學會乳腺病專業委員會八次會議的乳腺增生的診斷標準,分為兩組,治療組運用消結湯內服閤舒乳散外用進行治療,觀察其治療效果。結果:治療組50例中,治愈34例,佔68%;顯效7例,佔14%;好轉7例,佔14%;無效2例,佔4%;總有效率為96%。對照組50例中.治愈9例,佔18%;顯效11例,佔22%;好轉19例,佔38%;無效11例,佔22%;總有效率為78%。治療組總有效率優于對照組,差異有統計學意義(P<0.05)。結論:消結湯內服閤舒乳散外用治療乳腺增生病的臨床效果好,值得推廣。
목적:탐토소결탕내복합서유산외용치료유선증생병림상분석。방법:100례환자도부합2002년중화중의외과학회유선병전업위원회팔차회의적유선증생적진단표준,분위량조,치료조운용소결탕내복합서유산외용진행치료,관찰기치료효과。결과:치료조50례중,치유34례,점68%;현효7례,점14%;호전7례,점14%;무효2례,점4%;총유효솔위96%。대조조50례중.치유9례,점18%;현효11례,점22%;호전19례,점38%;무효11례,점22%;총유효솔위78%。치료조총유효솔우우대조조,차이유통계학의의(P<0.05)。결론:소결탕내복합서유산외용치료유선증생병적림상효과호,치득추엄。
Objective:To investigate the clinical effects of Shurusan for external use on the treatment of hyperplasia of mammary glands. Methods:One hundred and twenty patients accorded with the diagnostic criteria of hyperplasia of mammary glands established in the 8th academic conference of the professional committee of breast disease, Chinese Surgical Association of Chinese Medicine in 2002 were divided into two groups. Patients in the treatment group were treated with Shurusan, and the treatment effects were observed. Results:In 60 patients in the treatment group, 37 cases were cured, accounting for 61.67%;11 cases were treatedeffectively, accounting for 18.33%;9 cases were on the mend, accounting for 15%;3 cases were treated ineffectively, accounting for 5%;and the overall effective rate was 95%. In 60 patients in the control group, 12 cases were cured, accounting for 20%;13 cases were treated effectively, accounting for 21.67%;22 cases were on the mend, accounting for 36.67%;13 cases were treated ineffectively, accounting for 21.67%;and the overall effective rate was 78.33%. The overall effective rate of the treatment group was better than that of the control group, with a statistically significant difference (P<0.05). Conclusion:Shurusan for external use has good clinical effects on the treatment of hyperplasia of mammary glands. It is worth spreading in clinical practice.